Company / PP&E per Share
Sarepta Therapeutics PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$3.56
FY2025
5-year range
$2.07 / $3.63
FY2021-FY2025
Trend
-1.9%
vs FY2024
Sector context
#24 of 191
Health Care
What the data says
Sarepta Therapeutics's pp&e per share of $3.56 is higher than 87% of companies in the Health Care sector (FY2025). PP&E per Share has fluctuated over the past 10 years, ranging from $0.79 in FY2017 to $3.63 in FY2024.
Based on SEC 10-K filings.
3.56 in FY2025 with a 5-year CAGR of +7.1%. Top quartile in the Health Care sector.
Improved from $2.58 to $3.56 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +19.9%
- 5-Year CAGR
- +7.1%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 191This company $3.56 Sector average $22.34
▼
-84.1% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 1.9% year-over-year.
- Ranks #24 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.70 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.56 | -1.9% |
| FY2024 | $3.63 | +40.6% |
| FY2023 | $2.58 | +25.0% |
| FY2022 | $2.07 | -14.2% |
| FY2021 | $2.41 | -4.9% |
| FY2020 | $2.53 | +38.9% |
| FY2019 | $1.82 | +21.8% |
| FY2018 | $1.50 | +90.0% |
| FY2017 | $0.79 | -4.9% |
| FY2016 | $0.83 | -6.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026